CRIPPA, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 7.534
AS - Asia 6.805
NA - Nord America 5.187
SA - Sud America 1.443
AF - Africa 150
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.139
Nazione #
US - Stati Uniti d'America 4.925
RU - Federazione Russa 4.415
SG - Singapore 2.592
CN - Cina 2.018
BR - Brasile 1.183
HK - Hong Kong 835
SE - Svezia 727
IT - Italia 723
VN - Vietnam 628
FR - Francia 336
DE - Germania 300
RO - Romania 275
GB - Regno Unito 210
BD - Bangladesh 205
IN - India 164
FI - Finlandia 159
CA - Canada 140
AR - Argentina 94
MX - Messico 78
PL - Polonia 72
ES - Italia 61
NL - Olanda 61
JP - Giappone 55
IE - Irlanda 54
ZA - Sudafrica 49
ID - Indonesia 46
IQ - Iraq 44
AT - Austria 43
CO - Colombia 42
EC - Ecuador 36
TR - Turchia 34
LT - Lituania 25
PK - Pakistan 25
CL - Cile 24
MA - Marocco 23
PY - Paraguay 23
EG - Egitto 19
UZ - Uzbekistan 17
PH - Filippine 16
KE - Kenya 15
UA - Ucraina 15
UY - Uruguay 15
VE - Venezuela 15
SA - Arabia Saudita 14
DZ - Algeria 12
TN - Tunisia 12
IL - Israele 11
MD - Moldavia 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
BE - Belgio 10
IR - Iran 10
JM - Giamaica 10
NP - Nepal 10
BH - Bahrain 9
CR - Costa Rica 7
GE - Georgia 7
PE - Perù 7
RS - Serbia 7
JO - Giordania 6
HU - Ungheria 5
KG - Kirghizistan 5
MY - Malesia 5
DO - Repubblica Dominicana 4
EU - Europa 4
HN - Honduras 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
PA - Panama 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TH - Thailandia 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
LK - Sri Lanka 2
MK - Macedonia 2
NG - Nigeria 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 21.114
Città #
Singapore 1.215
Moscow 901
Hong Kong 824
Ashburn 780
Dallas 751
San Jose 636
Shanghai 370
Hefei 296
Beijing 271
New York 267
Lauterbourg 250
Ho Chi Minh City 228
Milan 196
Lawrence 191
Princeton 191
Los Angeles 172
Hanoi 134
São Paulo 131
Boardman 104
Santa Clara 94
Munich 88
Orem 88
Helsinki 83
Nuremberg 65
London 60
Denver 59
Rome 56
Montreal 54
Warsaw 51
Chennai 49
Dublin 49
Frankfurt am Main 48
Tokyo 44
Poplar 43
Rio de Janeiro 43
Turku 43
Council Bluffs 41
Chicago 40
Guangzhou 38
Atlanta 37
Brooklyn 36
Stockholm 36
Pune 35
Cesano Boscone 31
The Dalles 31
Johannesburg 30
Lappeenranta 30
Manchester 30
Phoenix 30
Belo Horizonte 29
Mexico City 29
Houston 28
Amsterdam 27
Washington 27
Boston 25
Toronto 25
Da Nang 23
Seattle 23
Brasília 22
San Francisco 21
Biên Hòa 20
Vienna 20
Haiphong 19
Hangzhou 19
Shenzhen 19
Buffalo 18
Columbus 18
Baghdad 17
Brescia 17
Campinas 17
Porto Alegre 17
Tianjin 17
Naples 16
Thái Bình 16
New Delhi 15
Tashkent 15
Querétaro 14
Ankara 13
Cape Town 13
Dhaka 13
Guarulhos 13
Montevideo 13
Quito 13
Santiago 13
Assago 12
Charlotte 12
City of London 12
Curitiba 12
Hải Dương 12
Jakarta 12
Mumbai 12
Falkenstein 11
Nairobi 11
Salvador 11
Al Mansurah 10
Bắc Ninh 10
Jiaxing 10
Lahore 10
Paris 10
Turin 10
Totale 10.211
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 355
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 189
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 169
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 166
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 159
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 148
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 142
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 141
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 140
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 139
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 134
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 134
A multimodality test to guide the management of patients with a pancreatic cyst 133
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 132
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 130
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 128
A preoperative score to predict early death after pancreatic cancer resection 127
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 126
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 126
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 123
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 122
The impact of preoperative anemia on pancreatic resection outcomes 119
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 119
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 118
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 116
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma 115
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 114
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 114
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 113
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 113
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 112
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 111
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 111
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 110
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 109
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 109
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 109
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 108
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 107
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 107
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 107
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 106
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 106
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 106
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 106
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 105
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 105
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 104
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 104
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 104
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 104
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 104
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 103
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 102
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 101
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 101
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 101
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 101
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 100
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 99
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 98
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 97
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 97
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 96
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 96
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 96
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 95
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 95
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 95
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 95
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 95
Risk factors for the occurrence of ampullary tumors: A case-control study 94
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 94
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 94
Validation of the PROMIS-29 Questionnaire as a Measure of Recovery After Pancreatic Surgery 93
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 93
Consensus guidelines on severe acute pancreatitis 92
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 92
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 90
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 90
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 89
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 89
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 87
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 87
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 85
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 85
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 85
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 85
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 85
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease 84
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 82
Acute pancreatitis at the beginning of the 21st century: the state of the art. 82
A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. 81
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 80
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 79
Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy? 79
Totale 11.040
Categoria #
all - tutte 121.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 0 6 50 7 3 7 5 8 12 4 8
2022/20231.296 451 269 96 6 12 169 88 98 58 7 13 29
2023/20241.090 33 41 110 137 107 221 24 113 21 38 83 162
2024/20254.446 474 96 129 157 182 346 837 395 693 452 298 387
2025/202614.500 1.001 1.079 890 1.996 1.151 468 1.218 1.096 3.969 837 642 153
Totale 21.534